The significance ofheregulinin breast cancer tumor progression and drug resistance
β Scribed by R. Lupu; M. Cardillo; C. Cho; L. Harris; M. Hijazi; C. Perez; K. Rosenberg; D. Yang; C. Tang
- Publisher
- Springer US
- Year
- 1996
- Tongue
- English
- Weight
- 870 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Reduction in apoptosis has been associated with tumor metastases and response to chemotherapy in breast cancer. We examine the influence of apoptosis status and the expression of antiapoptotic proteins Bcl-2 and Bcl-x(L) on metastatic progression and response to therapy in an experimental model of b
## Abstract Immunocytochemical (ICC) detection of disseminated tumor cells (DTC) in bone marrow (BM) in early breast cancer is an independent prognostic factor. The significance of circulating tumor cells (CTC) in peripheral blood (PB) needs further exploration and comparison to DTC detection. PB a
## Abstract Abnormal DNA methylation is a feature of most types of cancer, which is reflected in cellβfree circulating DNA in plasma. It is, however, unknown whether surgical removal of the tumor and subsequent therapy induces changes in plasma DNA methylation, which can be used to monitor treatmen